Keyphrases
Burkholderia Pseudomallei
100%
Pseudomallei
100%
Antimicrobial Therapy
100%
Interferon-α (IFN-α)
37%
Ceftazidime
37%
Combined Treatment
25%
Challenge Model
25%
Conventional Antimicrobials
25%
Active Immunization
25%
South-East Asia
12%
Interferon-γ
12%
Effective Treatment
12%
High Dose
12%
Soil Bacteria
12%
Inhibitory Effect
12%
Infected Mice
12%
Appropriate Antibiotic Therapy
12%
Antimicrobial
12%
Infected Macrophages
12%
Northern Australia
12%
Pneumonia
12%
Synergistic Inhibition
12%
Systemic Infection
12%
Infection Treatment
12%
Intracellular Replication
12%
Bacterial Burden
12%
Macrophage Infection
12%
Bacterial Dissemination
12%
Infection Assay
12%
Ultra-low Dose
12%
Prolonged Treatment
12%
Rapid Diagnosis
12%
Diagnosis Treatment
12%
Clinical Relapse
12%
Medicine and Dentistry
Melioidosis
100%
Infection
100%
Antimicrobial Therapy
100%
Immunotherapy
100%
Interferon
50%
Ceftazidime
50%
Macrophage
33%
Low Drug Dose
33%
Active Immunotherapy
33%
Burkholderia pseudomallei
16%
Sepsis
16%
Drug Megadose
16%
Antibiotic Therapy
16%
Cytokine
16%
Antiinfective Agent
16%
Gamma Interferon
16%
Immunology and Microbiology
Burkholderia pseudomallei
100%
interferon
100%
Immunotherapy
100%
Macrophage
66%
Low Drug Dose
66%
Active Immunotherapy
66%
Bacterial Load
33%
Interferon Gamma
33%
Cytokine
33%
Mouse
33%
Soil Microflora
33%
Drug Megadose
33%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Melioidosis
100%
Antimicrobial Therapy
100%
Immunotherapy
100%
Ceftazidime
50%
Interferon
50%
Burkholderia pseudomallei
16%
Mouse
16%
Antiinfective Agent
16%
Sepsis
16%
Antibiotic Therapy
16%
Soil Microflora
16%
Cytokine
16%
Gamma Interferon
16%